FIELD: medicine.
SUBSTANCE: offered agent concerns a chemico-pharmaceutical industry, and concerns agents of correction of metabolic disturbances after a liver cryolysis. The invention represents a solution of metronidazole for parenteral introduction in a dose of mass of a body of 20 mg/kg.
EFFECT: intensity depression of cellular membranes of hepatocytes phospholipids peroxidation by reduction of production of active forms of oxygen by a xanthine oxidase.
1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING STEATOHEPATOSIS IN EXPERIMENTAL ANIMALS | 2023 |
|
RU2811886C1 |
| HEPATOPROTECTOR | 2007 |
|
RU2329056C1 |
| METHOD FOR TREATING CHRONIC DISEASES (VARIANTS), METHOD FOR OBTAINING A BIOTRANSPLANT (VARIANTS), A BIOTRANSPLANT (VARIANTS) | 2006 |
|
RU2322248C2 |
| METHOD OF MODELLING CHRONIC TOXIC HEPATOPATHY | 2010 |
|
RU2440621C1 |
| COMPOSITION AND USING COMPOSITION FOR PREPARING DRUG HAVING HEPATOPROTECTIVE ACTIVITY | 2012 |
|
RU2485970C1 |
| METHOD FOR TREATING NEPHROANGIOPATHY COMBINED WITH ALLOXAN DIABETES IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2372898C1 |
| METHOD FOR SIMULATING CARBON TETRACHLORIDE-INDUCED TOXIC DAMAGE IN TOXICOLOGICAL EXPERIMENT | 2011 |
|
RU2487421C1 |
| METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
| MEDICATION POSSESSING HEPATOPROTECTIVE ACTION | 2009 |
|
RU2405562C1 |
| METHOD OF TOXIC LIVER DAMAGE REDUCTION | 2007 |
|
RU2342132C2 |
